COVID-19
Regístrese
Enfermedades Infecciosas y Microbiología Clínica
Suscribe to the journal
Buscar en
Enfermedades Infecciosas y Microbiología Clínica
Toda la web
Inicio Enfermedades Infecciosas y Microbiología Clínica Dermatological manifestations in onchocerciasis: A retrospective study of 400 im...
Journal Information
Back to article

Statistics

Follow this link to access the full text of the article

Original article
Dermatological manifestations in onchocerciasis: A retrospective study of 400 imported cases
Manifestaciones dermatológicas en oncocercosis: estudio retrospectivo de 400 casos importados
Sabino Puentea, German Ramirez-Olivenciab, Mar Lagoa, Mercedes Subiratsc, Eugenio Perez-Blazquezd, Fernando Brue, Teresa Garatef, Belén Vicenteg, Moncef Belhassen-Garciah, Antonio Murog,
Corresponding author
ama@usal.es

Corresponding author.
a Unidad de Medicina Tropical, Servicio de Medicina Interna, Hospital La Paz-Carlos III, Madrid, Spain
b Unidad de Aislamiento de Alto Nivel, Sección de Enfermedades Infecciosas, Servicio de Medicina Interna, Hospital Central de la Defensa Gómez Ulla, Madrid, Spain
c Microbiología, Hospital La Paz-Carlos III, Madrid, Spain
d Servicio de Oftalmología, Hospital Universitario 12 de Octubre, Universidad complutense de Madrid, Spain
e Dermatología, Madrid, Spain
f Parasitología, Centro Nacional de Microbiología, Instituto de Salud Carlos III, Majadahonda, Madrid, Spain
g Laboratorio de Inmunología Parasitaria y Molecular, CIETUS, IBSAL, Facultad de Farmacia, Universidad de Salamanca, Salamanca, Spain
h Servicio de Medicina Interna, Sección de Enfermedades Infecciosas, CAUSA, IBSAL, CIETUS, Universidad de Salamanca, Salamanca, Spain
Read
6074
Times
was read the article
1835
Total PDF
4239
Total HTML
Share statistics
Article information
ISSN: 0213005X
Original language: English
DOI:10.1016/j.eimc.2017.11.016
The statistics are updated each day
Year/Month Html Pdf Total
2024 April 48 27 75
2024 March 108 32 140
2024 February 98 51 149
2024 January 100 30 130
2023 December 110 41 151
2023 November 135 33 168
2023 October 152 44 196
2023 September 85 18 103
2023 August 80 11 91
2023 July 79 99 178
2023 June 86 44 130
2023 May 85 22 107
2023 April 51 15 66
2023 March 62 5 67
2023 February 43 11 54
2023 January 51 17 68
2022 December 77 30 107
2022 November 95 37 132
2022 October 77 24 101
2022 September 117 51 168
2022 August 88 36 124
2022 July 58 28 86
2022 June 43 25 68
2022 May 50 21 71
2022 April 73 35 108
2022 March 54 26 80
2022 February 72 22 94
2022 January 129 40 169
2021 December 70 32 102
2021 November 97 31 128
2021 October 122 37 159
2021 September 66 23 89
2021 August 54 24 78
2021 July 61 13 74
2021 June 73 34 107
2021 May 76 22 98
2021 April 127 44 171
2021 March 104 22 126
2021 February 73 15 88
2021 January 71 38 109
2020 December 55 14 69
2020 November 59 29 88
2020 October 58 15 73
2020 September 64 31 95
2020 August 56 23 79
2020 July 47 11 58
2020 June 46 22 68
2020 May 46 40 86
2020 April 39 48 87
2020 March 36 21 57
2020 February 31 19 50
2020 January 26 21 47
2019 December 51 30 81
2019 November 24 18 42
2019 October 37 17 54
2019 September 43 13 56
2019 August 27 9 36
2019 July 29 31 60
2019 June 49 38 87
2019 May 0 71 71
2019 April 2 6 8
2019 March 6 0 6
2019 February 2 3 5
2019 January 4 7 11
2018 December 24 19 43
2018 November 74 46 120
2018 August 0 1 1
2018 May 0 1 1
2018 March 0 2 2
2018 February 0 1 1
2018 January 3 12 15
2017 December 1 6 7
Show all

Follow this link to access the full text of the article

Subscribe to our newsletter

Publish in
Enfermedades Infecciosas y Microbiología Clínica
Special content about COVID-19
Free access articles
Executive summary of the consensus document on the shared...
Enferm Infecc Microbiol Clin. 2024;42:102-7
Executive Summary of the Consensus Statement of the Spanish...
Enferm Infecc Microbiol Clin. 2020;38:283-8
SARS-CoV-2 infection as trigger multisystem inflammatory...
Enferm Infecc Microbiol Clin. 2021;39:262-4


La Sociedad Española de Enfermedades Infecciosas y Microbiología Clínica agradece la colaboración de:

SOCIOS PROTECTORES

    - Pfizer GEP, S.L.U.
    - Shionogi, S.L.U.
    - AbbVie Spain, S.L.U.
    - Gilead Sciences, S.L.U.
    - Vircell Spain, S.L.U.
    - Roche Diagnostics, S.L.U.
    - ASTRAZENECA FARMACÉUTICA SPAIN, S.A.
    - Qiagen Iberia S.L.
    - Laboratorios ViiV Healthcare, S.L.

SOCIOS PATROCINADORES

- Becton Dickinson S.A.U.
- Janssen-Cilag, S.A.
- Angelini Farmacéutica, S.A.
- Biomerieux España, S,A.U.
- Merck Sharp & Dohme de España, S.A.
- Hologic Iberia, S.L.U.
- Laboratorios Menarini S.A.
- Accelerate Diagnostics S.L.
- Abbott Laboratories, S.A.
- Cepheid Iberia S.L.U.
- Illumina Productos de España. S.L.U.
- DiaSorin Iberia, S.A.
- GlaxoSmithKline, S.A.
- Sysmex España S.L.

Enfermedades Infecciosas y Microbiología Clínica follows the Recommendations for the Conduct, Reporting, Editing and Publication of Scholarly Work in Medical Journals

es en pt

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos